Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways

Biochemical Journal

Volumn 442, Issue 2, 2012, Pages 293-302

  Chang, Ming Cheng ^a,b   Chen, Chi An ^a   Chen, Pao Jen ^c   Chiang, Ying Cheng ^d   Chen, Yu Li ^a   Mao, Tsui Lien ^a   Lin, Han Wei ^a   Lin Chiang, Wen Hsien ^a   Cheng, Wen Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

c Jun N terminal kinase (JNK); Invasion; Matrix metalloproteinase (MMP); Mesothelin; Mitogen activated protein kinase (MAPK) extracellular signal regulated kinase (ERK); Ovarian cancer

Indexed keywords

MATRILYSIN; MESOTHELIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; FEMALE; GENE EXPRESSION; GPI-LINKED PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1;

ANIMALIA; MUS;

EID: 84863116491     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110282     Document Type: Article

References (46)

1. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (Pubitemid 37328786)
2. Sillanpaa, S., Anttila, M., Suhonen, K., Hamalainen, K., Turpeenniemi-Hujanen, T., Puistola, U., Tammi, M., Sironen, R., Saarikoski, S. and Kosma, V. M. (2007) Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol. 28, 280-289 (Pubitemid 350165834)
3. Noriyuki, M., Sumi, T., Zhi, X., Misugi, F., Nobeyama, H., Yoshida, H., Matsumoto, Y., Yasui, T., Honda, K. and Ishiko, O. (2007) Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women. Int. J. Oncol. 31, 531-536
4. Gaire, M., Magbanua, Z., McDonnell, S., McNeil, L., Lovett, D. H. and Matrisian, L. M. (1994) Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem. 269, 2032-2040 (Pubitemid 24035410)
5. Chambers, A. F. and Matrisian, L. M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270 (Pubitemid 27371946)
6. Rudolph-Owen, L. A., Chan, R., Muller, W. J. and Matrisian, L. M. (1998) The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res. 58, 5500-5506 (Pubitemid 28551137)
7. Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. and Matrisian, L. M. (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. U.S.A. 94, 1402-1407 (Pubitemid 27087863)
8. Yamamoto, H., Itoh, F., Adachi, Y., Sakamoto, H., Adachi, M., Hinoda, Y. and Imai, K. (1997) Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 112, 1290-1296 (Pubitemid 27157543)
9. Bast, Jr, R. C., Klug, T. L., St John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L. et al. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309, 883-887 (Pubitemid 13014028)
10. Chang, K., Pastan, I. and Willingham, M. C. (1992) Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. Int. J. Cancer 50, 373-381
11. Chang, K. and Pastan, I. (1996) Molecular cloning of MSLN, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc. Natl. Acad. Sci. U.S.A. 93, 136-140 (Pubitemid 26041483)
12. Argani, P., Iacobuzio-Donahue, C., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E., Yeo, C. J. et al. (2001) Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin. Cancer Res. 7, 3862-3868 (Pubitemid 34044602)
13. Hippo, Y., Yashiro, M., Ishii, M., Taniguchi, H., Tsutsumi, S., Hirakawa, K., Kodama, T. and Aburatani, H. (2001) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 61, 889-895 (Pubitemid 32174397)
14. Frierson, Jr, H. F., Moskaluk, C. A., Powell, S. M., Zhang, H., Cerilli, L. A., Stoler, M. H., Cathro, H. and Hampton, G. M. (2003) Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum. Pathol. 34, 605-609 (Pubitemid 36750373)
15. Chang, M. C., Chen, C. A., Hsieh, C. Y., Lee, C. N., Su, Y. N., Hu, Y. H. and Cheng, W. F. (2009) Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. Biochem. J. 424, 449-458
16. Hassan, R., Bera, T. and Pastan, I. (2004) Mesothelin: a new target for immunotherapy. Clin. Cancer Res. 10, 3937-3942 (Pubitemid 38812466)
17. Huang, C. Y., Cheng, W. F., Lee, C. N., Su, Y. N., Chien, S. C., Tzeng, Y. L., Hsieh, C. Y. and Chen, C. A. (2006) Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor. Anticancer Res. 26, 4721-4728
18. Cheng, W. F., Hung, C. F., Chai, C. Y., Chen, C. A., Lee, C. N., Su, Y. N., Tseng, W. Y., Hsieh, C. Y., Shih Ie, M., Wang, T. L. and Wu, T. C. (2007) Generation and characterization of an ascitogenic mesothelin-expressing tumor model. Cancer 110, 420-431
19. Reference deleted
20. Fingleton, B. M., Heppner Goss, K. J., Crawford, H. C. and Matrisian, L. M. (1999) Matrilysin in early stage intestinal tumorigenesis. APMIS 107, 102-110 (Pubitemid 29133529)
21. Chu, C. Y., Cha, S. T., Chang, C. C., Hsiao, C. H., Tan, C. T., Lu, Y. C., Jee, S. H. and Kuo, M. L. (2007) Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 α-directed invasion of human basal cell carcinoma cells. Oncogene 26, 2491-2501
22. Chen, Y. C., Su, Y. N., Chou, P. C., Chiang, W. C., Chang, M. C., Wang, L. S., Teng, S. C. and Wu, K. J. (2005) Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 280, 32505-32511
23. Ganesan, K., Ivanova, T., Wu, Y., Rajasegaran, V., Wu, J., Lee, M. H., Yu, K., Rha, S. Y., Chung, H. C., Ylstra, B. et al. (2008) Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel β-catenin/TCF target gene. Cancer Res. 68, 4277-4286
24. Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Risberg, B., Ben-Baruch, G. and Reich, R. (2003) Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? Cancer Metastasis Rev. 22, 103-115 (Pubitemid 36363519)
25. Jhala, N., Jhala, D., Vickers, S. M., Eltoum, I., Batra, S. K., Manne, U., Eloubeidi, M., Jones, J. J. and Grizzle, W. E. (2006) Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates. Am. J. Clin. Pathol. 126, 572-579
26. Swierczynski, S. L., Maitra, A., Abraham, S. C., Iacobuzio-Donahue, C. A., Ashfaq, R., Cameron, J. L., Schulick, R. D., Yeo, C. J., Rahman, A., Hinkle, D. A. et al. (2004) Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum. Pathol. 35, 357-366 (Pubitemid 38339611)
27. Creaney, J., Christansen, H., Lake, R., Musk, A. B., de Klerk, N. and Robinson, B. W. (2006) Soluble mesothelin related protein in mesothelioma. J. Thorac. Oncol. 1, 172-174 (Pubitemid 47164007)
28. Siu, M. K., Chan, H. Y., Kong, D. S., Wong, E. S., Wong, O. G., Ngan, H. Y., Tam, K. F., Zhang, H., Li, Z., Chan, Q. K. et al. (2010) p21-Activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc. Natl. Acad. Sci. U.S.A. 107, 18622-18627
29. Uehara, N., Matsuoka, Y. and Tsubura, A. (2008) Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells. Mol. Cancer Res. 6, 186-193 (Pubitemid 351342406)
30. Bermudez, Y., Yang, H., Cheng, J. Q. and Kruk, P. A. (2008) Pyk2/ERK1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor. Growth Factors 26, 1-11 (Pubitemid 351448009)
31. Kohno, M. and Pouyssegur, J. (2003) Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog. Cell Cycle Res. 5, 219-224
32. Gum, R., Wang, H., Lengyel, E., Juarez, J. and Boyd, D. (1997) Regulation of 92 kDa type IV collagenase expression by the Jun amino terminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481-1493 (Pubitemid 27182438)
33. Simon, C., Goepfert, H. and Boyd, D. (1998) Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58, 1135-1139 (Pubitemid 28183199)
34. Whitmarsh, A. J. and Davis, R. J. (2007) Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26, 3172-3184 (Pubitemid 46763013)
35. Lizundia, R., Chaussepied, M., Huerre, M., Werling, D., Di Santo, J. P. and Langsley, G. (2006) c-Jun NH2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria. Cancer Res. 66, 6105-6110
36. Kim, M., Murakami, A., Kawabata, K. and Ohigashi, H. (2005) (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis 26, 1553-1562 (Pubitemid 41236048)
37. Furuya, M., Ishikura, H., Ogawa, Y., Kawarada, Y., Shibata, M., Fujimoto, S. and Yoshiki, T. (2000) Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors. Pathobiology 68, 239-244 (Pubitemid 32757299)
38. Shigemasa, K., Tanimoto, H., Sakata, K., Nagai, N., Parmley, T. H., Ohama, K. and O'Brien, T. J. (2000) Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease. Med. Oncol. 17, 52-58 (Pubitemid 30159168)
39. Wen-Sheng, W. (2003) ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene 22, 955-963
40. Yamamoto, H., Itoh, F., Senota, A., Adachi, Y., Yoshimoto, M., Endoh, T., Hinoda, Y., Yachi, A. and Imai, K. (1995) Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells. J. Clin. Lab. Anal. 9, 297-301
41. Gustavson, M. D., Crawford, H. C., Fingleton, B. and Matrisian, L. M. (2004) Tcf binding sequence and position determines β-catenin and Lef-1 responsiveness of MMP-7 promoters. Mol. Carcinog. 41, 125-139 (Pubitemid 39435110)
42. Cheng, W. F., Huang, C. Y., Chang, M. C., Hu, Y. H., Chiang, Y. C., Chen, Y. L., Hsieh, C. Y. and Chen, C. A. (2009) High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma. Br. J. Cancer 100, 1144-1153
43. Hassan, R., Cohen, S. J., Phillips, M., Pastan, I., Sharon, E., Kelly, R. J., Schweizer, C., Weil, S. C. and Laheru, D. (2010) Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin expressing cancers. Clin. Cancer Res. 16, 6132-6138
44. Bogre, L., Meskiene, I., Heberle-Bors, E. and Hirt, H. (2000) Stressing the role of MAP kinases in mitogenic stimulation. Plant Mol. Biol. 43, 705-718
45. Choi, B. H., Kim, C. G., Bae, Y. S., Lim, Y., Lee, Y. H. and Shin, S. Y. (2008) p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res. 68, 1369-1377 (Pubitemid 351346844)
46. Uzgare, A. R. and Isaacs, J. T. (2004) Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Cancer Res. 64, 6190-6199 (Pubitemid 39129421)